|
COPYRIGHT 2006 Asia Pulse Pty Ltd
NEW DELHI, March 29 Asia Pulse - India's leading drug-maker Ranbaxy (BSE:600359) on Wednesday said it has acquired Terapia, the largest independent generic company in Romania, for US$324 million and aims to make that country its manufacturing hub in Europe.
The deal, which saw Ranbaxy acquiring 96.7 per cent...
Read the full article for free courtesy of your local library.
|